The Library
PERSEPHONE : duration of trastuzumab with chemotherapy in women with HER2-positive early breast cancer-six versus twelve months
Tools
Earl, H. M., Cameron, D. A., Miles, D., Wardley, A. M., Ogburn, E., Vallier, A. L., Loi, S., Higgins, H. B., Hiller, Louise and Dunn, Janet A. (2013) PERSEPHONE : duration of trastuzumab with chemotherapy in women with HER2-positive early breast cancer-six versus twelve months. Journal of Clinical Oncology, 31 (15). p. 1. doi:10.1200/jco.2014.32.15_suppl.tps656
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: https://doi.org/10.1200/jco.2014.32.15_suppl.tps65...
Item Type: | Journal Item | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) | ||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Journal or Publication Title: | Journal of Clinical Oncology | ||||
Publisher: | American Society of Clinical Oncology | ||||
ISSN: | 0732-183X | ||||
Official Date: | 20 May 2013 | ||||
Dates: |
|
||||
Volume: | 31 | ||||
Number: | 15 | ||||
Page Range: | p. 1 | ||||
DOI: | 10.1200/jco.2014.32.15_suppl.tps656 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |